Antiva Bio Presents Data from Phase 1b/2 Study of ABI-2280
14 Apr 2026 //
BUSINESSWIRE
Antiva Reports Positive Ph1b/2 Data for ABI-2280 in hrHPV
27 Aug 2025 //
PR NEWSWIRE
Antiva Biosciences Announces Scientific And Development Advisory Board
13 Jun 2024 //
PR NEWSWIRE
Antiva Biosciences Strengthens Leadership with Key New Appointments
19 Oct 2023 //
PR NEWSWIRE

Market Place
Sourcing Support